AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Return on Assets

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥1T
P/E ratio
10.9x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Mar 31, 20252.9-109.27%
Mar 31, 2024-30.8+405.74%
Mar 31, 2023-6.1-241.53%
Mar 31, 20224.3-1.82%
Mar 31, 20214.4+12.56%
Mar 31, 20203.9-34.01%
Mar 31, 20195.9-11.39%
Mar 31, 20186.7+72.80%
Mar 31, 20173.9+10.92%
Mar 31, 20163.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)